Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Convertible Debt: 2020

Historic Convertible Debt for Whitehawk Therapeutics (WHWK) over the last 1 years, with Dec 2020 value amounting to $1.1 million.

  • Whitehawk Therapeutics' Convertible Debt was N/A to $1.1 million in Q4 2020 from the same period last year, while for Dec 2020 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2020, which is N/A change from last year.
  • Latest data reveals that Whitehawk Therapeutics reported Convertible Debt of $1.1 million as of FY2020.
  • Whitehawk Therapeutics' Convertible Debt's 5-year high stood at $1.1 million during FY2020, with a 5-year trough of $1.1 million in FY2020.
  • Its 1-year average for Convertible Debt is $1.1 million, with a median of $1.1 million in 2020.